0001144204-14-016518.txt : 20140318 0001144204-14-016518.hdr.sgml : 20140318 20140318205134 ACCESSION NUMBER: 0001144204-14-016518 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140312 FILED AS OF DATE: 20140318 DATE AS OF CHANGE: 20140318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Robert E. JR CENTRAL INDEX KEY: 0001579672 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 14702515 BUSINESS ADDRESS: BUSINESS PHONE: 218-634-3500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST STREET 2: C/O BIOSANTE PHARMACEUTICALS, INC. CITY: BAUDETTE STATE: MN ZIP: 56623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meridian Venture Partners II, Co. CENTRAL INDEX KEY: 0001580169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1213 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 14702516 BUSINESS ADDRESS: STREET 1: 259 N. RADNOR-CHESTER ROAD STREET 2: SUITE 130 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 610-254-2999 MAIL ADDRESS: STREET 1: 259 N. RADNOR-CHESTER ROAD STREET 2: SUITE 130 CITY: RADNOR STATE: PA ZIP: 19087 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meridian Venture Partners II GP, L.P. CENTRAL INDEX KEY: 0001580170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1213 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 14702517 BUSINESS ADDRESS: STREET 1: 259 N. RADNOR-CHESTER ROAD STREET 2: SUITE 130 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 610-254-2999 MAIL ADDRESS: STREET 1: 259 N. RADNOR-CHESTER ROAD STREET 2: SUITE 130 CITY: RADNOR STATE: PA ZIP: 19087 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERIDIAN VENTURE PARTNERS II LP CENTRAL INDEX KEY: 0001109507 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 14702518 BUSINESS ADDRESS: STREET 1: 259 RADNOR CHESTER ROAD STREET 2: SUITE 140 CITY: RADNOR STATE: PA ZIP: 19087 4/A 1 v372127_4a.xml OWNERSHIP DOCUMENT X0306 4/A 2014-03-12 2014-03-14 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001109507 MERIDIAN VENTURE PARTNERS II LP 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 0 0 1 0 0001580170 Meridian Venture Partners II GP, L.P. 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 0 0 1 0 0001580169 Meridian Venture Partners II, Co. 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 0 0 1 0 0001579672 Brown Robert E. JR C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 0 0 0 Common Stock 2014-03-12 4 S 0 32802 33.61 D 2786942 D Common Stock 2014-03-12 4 S 0 2517 34.33 D 2784425 D Common Stock 2014-03-13 4 S 0 33514 31.05 D 2750911 D Common Stock 2014-03-13 4 S 0 12138 32.53 D 2738773 D Common Stock 2014-03-13 4 S 0 6752 33.31 D 2732021 D On March 14, 2014, the reporting person filed a Form 4 that reported sales of the Issuer's securities, which Form 4 contained an inadvertent error in the amount of securities beneficially owned following the reported sales transaction. This Form 4 also corrects the method of reporting the prices of the securities sold. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $34.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale. Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.20 to $34.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.05 to $32.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale. /s/ Robert E. Brown, Jr. 2014-03-18